Author's Reply to Sener and Begijanashvili: "Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy"

被引：0
|
作者：
Sheng, Iris Y. [1 ]
Khorana, Alok A. [2 ]
机构：
[1] Beth Israel Lahey Mt Auburn Hosp, Dept Med, Boston, MA USA
[2] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, 10201 Carnegie Ave CA 60, Cleveland, OH 44106 USA
来源：
TARGETED ONCOLOGY | 2022年 / 17卷 / 04期
关键词：
QTC-INTERVAL PROLONGATION; TUMOR THROMBUS; MANAGEMENT;
D O I：
10.1007/s11523-022-00895-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 496
页数：2
相关论文
共 50 条
  • [41] Prognostic factors of immunotherapy in metastatic renal cell carcinoma
    Peeter Padrik
    Medical Oncology, 2003, 20 : 325 - 334
  • [42] Combination of surgery and immunotherapy in metastatic renal cell carcinoma
    Mickisch, GH
    Mattes, RH
    WORLD JOURNAL OF UROLOGY, 2005, 23 (03) : 191 - 195
  • [43] Biomarkers of Inflammation and Progression During Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
    Spisarova, Martina
    Melichar, Bohuslav
    Juranova, Jarmila
    Zemankova, Anezka
    Adam, Tomas
    Matousova, Katerina
    Javorska, Lenka
    Krcmova, Lenka Kujovska
    Turonova, Dorota
    Studentova, Hana
    IN VIVO, 2023, 37 (01): : 393 - 399
  • [44] Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma
    Donskov, Frede
    DANISH MEDICAL BULLETIN, 2007, 54 (04) : 249 - 265
  • [45] Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
    Dawsey, Scott J.
    Ornstein, Moshe C.
    CURRENT ONCOLOGY, 2021, 28 (06) : 5019 - 5024
  • [46] Comorbidity burden and effectiveness of immunotherapy in patients with metastatic renal cell carcinoma.
    Yekeduz, Emre
    Zarba, Martin
    Saad, Eddy
    Wells, Connor
    Machaalani, Marc
    Chehade, Razane El Hajj
    Eid, Marc
    Labaki, Chris
    Nawfal, Rashad
    Saliby, Renee Maria
    Semaan, Karl
    Steiner, Clara
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [47] Unexpected hyperparathyroidism in metastatic renal cell carcinoma patients treated with sunitinib
    Mazzanti, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [48] Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib
    Keizman, Daniel
    Sarid, David
    Lee, Jae L.
    Sella, Avishay
    Gottfried, Maya
    Hammers, Hans
    Eisenberger, Mario A.
    Carducci, Michael A.
    Sinibaldi, Victoria
    Neiman, Victoria
    Rosenbaum, Eli
    Peer, Avivit
    Neumann, Avivit
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Yildiz, Ibrahim
    ONCOLOGIST, 2016, 21 (10): : 1212 - 1217
  • [49] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Feldman, Darren R.
    Martorella, Andrew J.
    Robbins, Richard J.
    Motzer, Robert J.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 974 - 975
  • [50] Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib
    Neiman, V.
    Keizman, D.
    Sarid, D.
    Lee, J-L.
    Sella, A.
    Gottfried, M.
    Hammers, H.
    Eisenberger, M.
    Carducci, M.
    Sinibaldi, V.
    Rosenbaum, E.
    Peer, A.
    Neumann, A.
    Mermershtain, W.
    Rouvinov, K. R.
    Berger, R.
    Yildiz, I.
    ANNALS OF ONCOLOGY, 2016, 27
12345